Lexaria Bioscience Corp. Up to $5,925,000 of Shares of Common Stock Equity Distribution AgreementEquity Distribution Agreement • August 12th, 2022 • Lexaria Bioscience Corp. • Pharmaceutical preparations • New York
Lexaria Bioscience Corp., a Nevada corporation (the “Company”), proposes to issue and sell through Maxim Group LLC (the “Agent”), as exclusive sales agent, shares of common stock, par value $0.001 per share (“Common Stock”), of the Company (the “Shares”) having an aggregate offering price of up to $5,925,000 on terms set forth herein. The Shares consist entirely of authorized but unissued shares of Common Stock to be issued and sold by the Company.
